Trial Profile
Fampridine treatment to improve fatigue in chronic inflammatory demyelinating polyneuropathy (CIDP)
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Chronic inflammatory demyelinating polyradiculoneuropathy
- Focus Therapeutic Use
- Acronyms FAMP-CIDP
- 25 Jun 2016 New trial record